Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Biden’s CUREIT initiative aims to develop a toolbox of technologies to fight cancer, autoimmune disorders and infectious diseases.
Monoclonal antibodies used to prevent COVID-19 in immunocompromised people aren’t active against new virus variants.
Older people, immunocompromised people and those with underlying health conditions can benefit most from additional shots.
HIV-positive heart transplant recipient (and cancer survivor) Miriam Nieves meets the family of the HIV-positive donor, Brittany Newton.
Latinos are facing challenges and barriers such as language, immigration status and discrimination.
The recipient was a woman in her 60s living with HIV.
CoVac-1 induced T-cell responses in about 90% of immunocompromised people with impaired B-cell function.
While vaccination typically provides robust protection against severe disease, they’re less effective for immunocompromised people.
Immunocompromised people ages 12 and older are also eligible for an additional shot.
Protecting the immunocompromised is not only a matter of health equity, it’s critical to ending the pandemic.
The CDC’s move triggered mixed feelings from the public and laid bare a split within the health care community.
Transplant recipients, people with advanced HIV and certain people with cancer or autoimmune diseases can get an additional vaccine dose.
Boosters reduced the risk of hospitalization and death by about 80% for people with HIV, cancer, autoimmune conditions or organ transplants.
Boosters further reduce the risk of severe illness and can help curb coronavirus transmission.
Post-exposure and pre-exposure prophylaxis could be a game-changer for immunocompromised people.
A growing number of transplant programs are barring patients who refuse COVID vaccines or giving them lower priority on waiting lists.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.